Boehringer Ingelheim ‘Providing Value through Innovation’. Boehringer Ingelheim is committed to attitude of constant change that means innovating, and creating value that we seek in order to provide better products and services to their customers- meeting their needs and exceeding their expectations.
In Mexico, Boehringer Ingelheim also invests in clinical research; an important phase for the development of a drug. In 2008, the budget for these investments totaled $ 25,685 million pesos, which makes us one of the pharmaceutical companies that invest most in this area of the world.
Maíz No. 49, Barrio Xaltocan, Xochimilco,
Tel: +52 55 5629 8300